- What Gen Z’s ‘career chameleon’ era means for healthcare
- After 3 decades at Emory, clinical exec joins Indiana University
- CVS Health Ventures leads $40M investment in AI company
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- The week in hospital M&A
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Kentucky system taps Medline as prime lab vendor
- Salina Regional seeks approval for new ASC
- Kentucky hospital names CEO
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- Gastroenterologist named Cleveland Clinic chief of staff
- 5 joint replacement surgeons to watch
- The ‘secret sauce’ behind Northwestern Medicine’s supply chain strategy
- 10 systems seeking supply chain leaders
- Orlando Health posts 1.9% margin, sees ‘early indications’ of payer mix shift
- 6 hospitals, health systems shuttering services
- A new behavioral health profession is born
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- What health systems keep getting wrong about ASCs
- Dentists pay climbed the most in these 10 states
- Cardiologist wins NIH grant targeting heart failure’s hidden toll
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Long COVID Might Be Twice As Common As Previously Thought
- Drug Effective In Slowing Progressive MS, Trial Shows
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- ‘Impossible to survive in a silo’: How a surgical group has stayed independent for 50 years
- Where 3 certificate-of-need laws stand
- What’s fueling optimism for dentistry’s future
- Palomar Health’s outpatient arm experiences data incident
- American Academy of Pediatric Dentistry installs new president, officers
- Phase 1 Equity adds multilocation practice in Texas
- 4 key stats on the oral surgeon workforce
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- Dr. Emile Rossouw appointed president of the American Board of Orthodontics
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- 6 trends reshaping DSO activity
- Former Florida dental practice employee accused of destroying documents
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Listen to the Latest ‘KFF Health News Minute’
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- ‘Standardize what protects the patient’: The balancing act in behavioral healthcare operations
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Nebraska behavioral health workforce grew 49% since 2010: 4 notes
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trinity Health credits pay rates, cost management for its steady 1% operating margin
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- CVS sues to challenge Tennessee's new PBM law
- Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- SK bioscience links up with Colombia to enable local production of varicella vaccine
- After prior FDA manufacturing snub, Gilead's hepatitis D med Hepcludex nabs US nod
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Cheaper, Alternative Health Plans Are Having a Moment, but Critics Urge Caution
- Wheel, b.well partner to build turnkey infrastructure behind AI-native virtual care
- Journalists Distill News on Ebola, Licensing Midwives, and California’s Budget
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
The Centers for Medicare & Medicaid Services (CMS) is almost hopelessly behind in their Medicare Advantage (MA) plan audits, going back to payment year (PY)2018. The new CMS Director, Dr. Mehmet OZ, has directed CMS to audit all eligible MA contracts for each payment year and will invest additional resources to expedite the completion of audits for payment years 2018 through 2024. The savings from these audits should cover their costs:
Dr. Oz Must Tackle MA Fraud, One Insurer at a Time
By Marion Mass - June 09, 2025CMS Director Mehmet Oz just directed the agency to double down on auditing Medicare Advantage (MA) plans to root out waste and fraud. In the same week, Senate Republicans signalled the same scrutiny. Americans should be cheering these moves that could keep Medicare sustainable.
For years, lawmakers and agencies like CMS alike have seen evidence that MA plan insurers routinely overcharge the government by billions, leaving the average taxpayer to foot the bill. This fraud is unacceptable – and it’s just for Congress and the Administration to stomp it out.
Starting with this audit, Director Oz ought to send a clear message to insurers that have practiced rampant abuse of taxpayer dollars: We have zero tolerance for fraud, waste, and abuse.
Medicare Advantage, when created, allowed Medicare patients to have a choice of a private coverage option. But the very makeup of these plans invite insurers to game the system.
Private insurers that run MA plans will take any chance they can to increase their margins and bleed Medicare dry. Countless MA insurers charged the government for diagnoses based on shoddy health screening done in-house, according to a 2021 Inspector General’s report. It’s not a new problem, either – MA overbilling goes back to 2012, when CMS found $12 billion of this fraud under the Obama administration.
The fraud has only ballooned since then. Today, MA insurers bill $140 billion in excess of what treatments were required for U.S. patients, according to the Center for Medicare Advocacy. Some health plans over-bill by up to $5,888 per patient for standard treatments.
Should Americans expect this additional cash flow to go to patients? Of course not. Nearly one-third of all American healthcare expenditures go to administrative costs and fees, according to a survey from the Commonwealth Fund. That means more money towards suits and less to the ‘scrubs’ helping the patients.
The government must take a stand against this misuse of funds. CMS Director Oz is starting now. Here’s a few pointed suggestions.
CMS needs to step in at the root of the problem: “Upcoding.” Medicare Advantage patients are diagnosed with more severe conditions than they actually have, if they even have them at all. The result is a much larger check for the insurers running the MA plans, coming right out of the coffers of American taxpayers.
The worst offenses happen outside the doctor’s office. Insurers often send non-physician employees to patients’ homes, administer “Health Risk Assessments”, which results in the upcoding. United Healthcare, who runs more MA plans and who stands accused of upcoding more than any than any other insurer, employs or is associated with 10% of America’s practicing physicians. It’s hard to imagine that this perverse incentive has not been used by United to help their bottom line.
CMS Director Oz should work with lawmakers to bar insurers from upcoding and mandate that actual non-conflicted physicians perform screenings for insurance purposes. These two simple changes could prevent insurers from ripping off the government – and the government can prevent these insurers from mishandling millions of patients’ illnesses.
Dr. Oz would be wise to have CMS broadcast exactly which insurers are responsible for upcoding, so Americans interested in purchasing Medicare Advantage plans can make well informed choices.
Lastly, large insurance company subsidiaries have a history of unfairly clawing back money in the pharmacy space. Any fraudulently collected upcoded money must be clawed back with deserved impunity.
It’s more important than ever to start now. More than 40 million Americans are expected to enroll in MA plans by 2030. Insurers must be thrilled at the growing opportunity to defraud the government, but policymakers are worried. The more seniors and at-risk patients enrolled in MA plans, the more that lawmakers need to control costs without denying care. Banning practices like upcoding and Health Risk Assessments prevent these costs from spiraling.
Director Oz has in the past been an outspoken advocate for Medicare Advantage. Yet while Oz’s opponents called him out for pushing pro-insurance talking points, this audit shows that he’s anything but a shill. Taking MA reforms a step further allows him make good on his promise to “stop unscrupulous people from stealing from vulnerable Americans.” He and CMS as a whole must hold insurers accountable for their actions to make Medicare as solvent as it can be.
Auditing insurers is a great place to start – but it’s only a start. To fully eradicate this waste, fraud, and abuse, CMS needs to back up its words with actions.
Marion Mass, M.D. is a Bucks County, PA pediatrician and the co-founder of the Practicing Physicians of America.
The CMS Medicare Advantage Audit Press Release:
CMS Rolls Out Aggressive Strategy to Enhance and Accelerate Medicare Advantage Audits
Agency Will Begin Auditing All Eligible Medicare Advantage Contracts Each Payment Year and Add Resources to Expedite Completion of 2018 to 2024 AuditsMay 25, 2025
Today, the Centers for Medicare & Medicaid Services (CMS) announced a significant expansion of its auditing efforts for Medicare Advantage (MA) plans. Beginning immediately, CMS will audit all eligible MA contracts for each payment year in all newly initiated audits and invest additional resources to expedite the completion of audits for payment years 2018 through 2024.
“We are committed to crushing fraud, waste and abuse across all federal healthcare programs,” said Dr. Mehmet Oz, CMS Administrator. “While the Administration values the work that Medicare Advantage plans do, it is time CMS faithfully executes its duty to audit these plans and ensure they are billing the government accurately for the coverage they provide to Medicare patients.”
Medicare Advantage plans receive risk-adjusted payments based on the diagnoses they submit for enrollees—meaning higher payments for patients with more serious or chronic conditions. To verify the accuracy of these claims, CMS conducts Risk Adjustment Data Validation (RADV) audits to confirm that diagnoses used for payment are supported by medical records.
Currently, CMS is several years behind in completing these audits. The last significant recovery of MA overpayments occurred following the audit of payment year (PY) 2007, despite federal estimates suggesting MA plans may overbill the government by approximately $17 billion annually. The Medicare Payment Advisory Commission (MedPAC) estimates this figure could be as high as $43 billion per year. CMS’s completed audits for PYs 2011–2013 found between 5% and 8% in overpayments.
To address this backlog, the Trump Administration has introduced a plan to complete all remaining RADV audits for PY 2018 to PY 2024 by early 2026. Key elements of the plan include:
Enhanced Technology: CMS will deploy advanced systems to efficiently review medical records and flag unsupported diagnoses.
Workforce Expansion: CMS will increase its team of medical coders from 40 to approximately 2,000 by September 1, 2025. These coders will manually verify flagged diagnoses to ensure accuracy.
Increased Audit Volume: By leveraging technology, CMS will be able to increase its audits from ~60 MA plans a year to all eligible MA plans each year in all newly initiated audits (approximately 550 MA plans). CMS will also be able to increase from auditing 35 records per health plan per year to between 35 and 200 records per health plan per year in all newly initiated audits based on the size of the health plan. This will help ensure CMS’s audit findings are more reliable and can be appropriately extrapolated as allowed under the RADV final rule.
In addition to these efforts, CMS will collaborate with the Department of Health and Human Services Office of Inspector General (HHS-OIG) to recover uncollected overpayments identified in past audits. CMS reaffirms its commitment to ensuring all Medicare Advantage plans comply with federal requirements and accurately report patient diagnoses used for payment.
It appears that AHIP has enough Republican U.S. Senators kowtowing to kill off any changes in Medicare Advantage. Dr. Oz will certainly get the message:
Republicans back off Medicare changes in GOP megabill
An effort to get savings from reforms to popular Medicare Advantage plans is failing to gain ground in the Senate.By Jordain Carney and Robert King - June 10, 2025
Senate Republicans appear to be popping their own trial balloon on including changes to Medicare as part of their “big beautiful bill.”
The public shift comes after GOP senators caught their own colleagues off guard — and gave Democrats a new political target — when they opened the door last week to going after “waste, fraud and abuse” within the program to capture savings to satisfy their deficit hawks.
But Sen. Kevin Cramer (R-N.D.), who raised the concept after a closed-door conference meeting last week, said in a brief interview Tuesday that he now doesn’t expect Republicans to actually grab one of their third rails as an offset for President Donald Trump’s sweeping megabill.
When asked if he expects Medicare changes to make it into the massive tax and spending package, Cramer replied, “I don’t know that I do. There aren’t many of us courageous enough to talk about it.” He also acknowledged that his previous remarks sparked “a lot of angst.”
Republicans also last week floated potentially including bipartisan legislation from Sens. Bill Cassidy (R-La.) and Jeff Merkley (D-Ore.) that would target overpayment in Medicare Advantage plans, which enables older Americans to buy private plans offering health coverage. It could lead to tens of billions of dollars in savings.
Many GOP senators, however, raised concerns publicly and privately about including language from that bill as part of the larger tax and spending package.
Sen. Josh Hawley (R-Mo.) said Tuesday he’d spoken with Trump directly and the president wasn’t in favor of doing anything on Medicare.
“He said people who play around with Medicare lose elections,” Hawley said.
The major insurance industry group AHIP also weighed in, warning that the bill would lead to higher costs and reductions in benefits. Moderates in the House also sounded the alarm bells that Senate Republicans appeared to be reviving an idea they had earlier rejected as a pay-for in their version of the legislation.
Even members of the Senate Finance Committee poured cold water on the likelihood that it would be included in draft text their panel could release as soon as Friday. The pushback isn’t based on opposition to the proposal itself but questions about if the megabill is the right venue to advance this particular policy.
“There is a lot of work to be done to make sure you don’t have unintended consequences. But I think that is an area for longer-term gain. I don’t know that you can necessarily, in the horizon that we’re operating [in], be able to book some of the savings that may be out there,” said Sen. Thom Tillis (R-N.C.) about the Cassidy-Merkley measure specifically.
Asked if he expected it would be included in the legislation, Sen. John Barrasso (R-Wyo.), the Senate majority whip and a member of the Finance Committee, instead said it would be in the conference’s “discussions.”
Republicans will meet Wednesday to receive a briefing by GOP senators crafting outstanding portions of the bill, including Finance Chair Mike Crapo (R-Idaho).
Cassidy’s office did not immediately return a request for comment on the status of discussions around his policy proposal, but he has previously said his legislation does not cut benefits. Rather, he has argued it would remove tools that Medicare Advantage plans employ to garner higher payments from the federal government by making patients appear sicker than they actually are.
“This addresses an issue both Republicans and Democrats have called waste, fraud and abuse,” Cassidy said Friday.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















